Literature DB >> 23245197

Delay discounting in adults receiving treatment for marijuana dependence.

Erica N Peters1, Nancy M Petry, Donna M Lapaglia, Brady Reynolds, Kathleen M Carroll.   

Abstract

Delay discounting is an index of impulsive decision-making and reflects an individual's preference for smaller immediate rewards relative to larger delayed rewards. Multiple studies have indicated comparatively high rates of discounting among tobacco, alcohol, cocaine, and other types of drug users, but few studies have examined discounting among marijuana users. This report is a secondary analysis of data from a clinical trial that randomized adults with marijuana dependence to receive one of four treatments that involved contingency management (CM) and cognitive-behavioral therapy interventions. Delay discounting was assessed with the Experiential Discounting Task (Reynolds & Schiffbauer, 2004) at pretreatment in 93 participants and at 12 weeks posttreatment in 61 participants. Results indicated that higher pretreatment delay discounting (i.e., more impulsive decision-making) significantly correlated with lower readiness to change marijuana use (r = -0.22, p = .03) and greater number of days of cigarette use (r = .21, p = .04). Pretreatment discounting was not associated with any marijuana treatment outcomes. CM treatment significantly interacted with time to predict change in delay discounting from pre- to posttreatment; participants who received CM did not change their discounting over time, whereas those who did not receive CM significantly increased their discounting from pre- to posttreatment. In this sample of court-referred young adults receiving treatment for marijuana dependence, delay discounting was not strongly related to treatment outcomes, but there was some evidence that CM may protect against time-related increases in discounting. (c) 2013 APA, all rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23245197      PMCID: PMC3659159          DOI: 10.1037/a0030943

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  57 in total

1.  Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls.

Authors:  N M Petry
Journal:  Psychopharmacology (Berl)       Date:  2001-03       Impact factor: 4.530

2.  Delay discounting is associated with treatment response among cocaine-dependent outpatients.

Authors:  Yukiko Washio; Stephen T Higgins; Sarah H Heil; Todd L McKerchar; Gary J Badger; Joan M Skelly; Robert L Dantona
Journal:  Exp Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.157

3.  Mild opioid deprivation increases the degree that opioid-dependent outpatients discount delayed heroin and money.

Authors:  Louis A Giordano; Warren K Bickel; George Loewenstein; Eric A Jacobs; Lisa Marsch; Gary J Badger
Journal:  Psychopharmacology (Berl)       Date:  2002-07-13       Impact factor: 4.530

4.  The Experiential Discounting Task is sensitive to cigarette-smoking status and correlates with a measure of delay discounting.

Authors:  Brady Reynolds
Journal:  Behav Pharmacol       Date:  2006-03       Impact factor: 2.293

5.  Delay discounting decreases in those completing treatment for opioid dependence.

Authors:  Reid D Landes; Darren R Christensen; Warren K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  2012-02-27       Impact factor: 3.157

6.  Reward discounting as a measure of impulsive behavior in a psychiatric outpatient population.

Authors:  J P Crean; H de Wit; J B Richards
Journal:  Exp Clin Psychopharmacol       Date:  2000-05       Impact factor: 3.157

7.  Does delay discounting play an etiological role in smoking or is it a consequence of smoking?

Authors:  Janet Audrain-McGovern; Daniel Rodriguez; Leonard H Epstein; Jocelyn Cuevas; Kelli Rodgers; E Paul Wileyto
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

8.  Delay discounting and smoking: association with the Fagerström Test for Nicotine Dependence but not cigarettes smoked per day.

Authors:  Maggie M Sweitzer; Eric C Donny; Lisa C Dierker; Janine D Flory; Stephen B Manuck
Journal:  Nicotine Tob Res       Date:  2008-10       Impact factor: 4.244

9.  Test-retest reliability of a group-administered paper-pencil measure of delay discounting.

Authors:  Robert C Beck; Mary Frances Triplett
Journal:  Exp Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.157

10.  Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls.

Authors:  Kris N Kirby; Nancy M Petry
Journal:  Addiction       Date:  2004-04       Impact factor: 6.526

View more
  21 in total

1.  A comparison of delay discounting in adolescents and adults in treatment for cannabis use disorders.

Authors:  Dustin C Lee; Catherine Stanger; Alan J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2015-02-02       Impact factor: 3.157

Review 2.  The relationship between the UPPS-P impulsive personality traits and substance use psychotherapy outcomes: A meta-analysis.

Authors:  Alexandra R Hershberger; Miji Um; Melissa A Cyders
Journal:  Drug Alcohol Depend       Date:  2017-06-28       Impact factor: 4.492

3.  Unique prediction of cannabis use severity and behaviors by delay discounting and behavioral economic demand.

Authors:  Justin C Strickland; Joshua A Lile; William W Stoops
Journal:  Behav Processes       Date:  2017-03-24       Impact factor: 1.777

4.  Opportunity costs of reward delays and the discounting of hypothetical money and cigarettes.

Authors:  Patrick S Johnson; Evan S Herrmann; Matthew W Johnson
Journal:  J Exp Anal Behav       Date:  2014-11-12       Impact factor: 2.468

5.  A web-based episodic specificity and future thinking session modulates delay discounting in cannabis users.

Authors:  Michael J Sofis; Shea M Lemley; Dustin C Lee; Alan J Budney
Journal:  Psychol Addict Behav       Date:  2020-01-30

6.  Test-retest reliability and construct validity of the Experiential Discounting Task.

Authors:  Rochelle R Smits; Jeffrey S Stein; Patrick S Johnson; Amy L Odum; Gregory J Madden
Journal:  Exp Clin Psychopharmacol       Date:  2013-02-18       Impact factor: 3.157

7.  Heroin delay discounting: Modulation by pharmacological state, drug-use impulsivity, and intelligence.

Authors:  Jonathan J K Stoltman; Eric A Woodcock; Jamey J Lister; Leslie H Lundahl; Mark K Greenwald
Journal:  Exp Clin Psychopharmacol       Date:  2015-12       Impact factor: 3.157

Review 8.  Psychosocial interventions for cannabis use disorder.

Authors:  Peter J Gates; Pamela Sabioni; Jan Copeland; Bernard Le Foll; Linda Gowing
Journal:  Cochrane Database Syst Rev       Date:  2016-05-05

Review 9.  Neuropsychological Interventions for Decision-Making in Addiction: a Systematic Review.

Authors:  Antonio Verdejo-García; Miguel A Alcázar-Córcoles; Natalia Albein-Urios
Journal:  Neuropsychol Rev       Date:  2018-09-26       Impact factor: 7.444

Review 10.  The neurobiology of impulsivity and substance use disorders: implications for treatment.

Authors:  Karolina Kozak; Aliya M Lucatch; Darby J E Lowe; Iris M Balodis; James MacKillop; Tony P George
Journal:  Ann N Y Acad Sci       Date:  2018-10-05       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.